For valid reasons, MISSD accepts no money from the pharmaceutical industry. A new study finds that pharma-funded patient advocacy groups may be compromised which can lead to skewed priorities, biased information and dissemination, and recommendations that favor the industry’s interests over those of patients. Read the full article at http://Pharma funded patient advocacy groups is an oxymoron phrase… –advocacy efforts may be compromised –this could lead to skewed priorities –biased information dissemination, and –recommendations that favor the industry’s interests over those of patients.